In patients with ulcerative colitis, vedolizumab outperformed infliximab as a second-line therapy following failure of anti-TNF therapy.

Researchers at the National Institutes of Health (NIH) have determined that dermatitis resulting from topical steroid ...

There should not be a controversy over anabolic steroid use in athletics -- non-medical use of anabolic steroids is illegal and banned by most, if not all, major sports organizations. Still ...